These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The influence of elastin degradation products, glucose and atorvastatin on metalloproteinase-1, -2, -9 and tissue inhibitor of metalloproteinases-1, -2, -3 expression in human retinal pigment epithelial cells. Dorecka M; Francuz T; Garczorz W; Siemianowicz K; Romaniuk W Acta Biochim Pol; 2014; 61(2):265-70. PubMed ID: 24904926 [TBL] [Abstract][Full Text] [Related]
5. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary. Robinson LL; Sznajder NA; Riley SC; Anderson RA Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387 [TBL] [Abstract][Full Text] [Related]
7. Effect of infliximab on tumor necrosis factor-alpha-induced alterations in retinal microvascular endothelial cells and retinal pigment epithelial cells. Li H; Yoneda M; Takeyama M; Sugita I; Tsunekawa H; Yamada H; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M J Ocul Pharmacol Ther; 2010 Dec; 26(6):549-56. PubMed ID: 21054185 [TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079 [TBL] [Abstract][Full Text] [Related]
9. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells. Bagheri A; Soheili ZS; Ahmadieh H; Samiei S; Sheibani N; Astaneh SD; Kanavi MR; Mohammadian A Mol Vis; 2015; 21():378-90. PubMed ID: 25883524 [TBL] [Abstract][Full Text] [Related]
11. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Sillem M; Prifti S; Koch A; Neher M; Jauckus J; Runnebaum B Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):167-74. PubMed ID: 11301163 [TBL] [Abstract][Full Text] [Related]
12. TNF-α stimulates MMP-3 production via PGE2 signalling through the NF-kB and p38 MAPK pathway in a murine cementoblast cell line. Sanchavanakit N; Saengtong W; Manokawinchoke J; Pavasant P Arch Oral Biol; 2015 Jul; 60(7):1066-74. PubMed ID: 25956994 [TBL] [Abstract][Full Text] [Related]
13. Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells. Göõz M; Göõz P; Smolka AJ Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G823-32. PubMed ID: 11518695 [TBL] [Abstract][Full Text] [Related]
14. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106 [TBL] [Abstract][Full Text] [Related]
15. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Milner JM; Rowan AD; Cawston TE; Young DA Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants. Välimäki J; Uusitalo H Acta Ophthalmol; 2015 Aug; 93(5):450-456. PubMed ID: 25588965 [TBL] [Abstract][Full Text] [Related]
17. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts. Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699 [TBL] [Abstract][Full Text] [Related]
19. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition. Li H; Simon H; Bocan TM; Peterson JT Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234 [TBL] [Abstract][Full Text] [Related]
20. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]